NCT06944067View on ClinicalTrials.gov

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

April 10, 2030

Study Completion Date

April 10, 2030

Conditions

Sickle Cell Disease

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Human Genome Research Institute (NHGRI)

NIH